Sino Bioenergy Past Earnings Performance
Past criteria checks 0/6
Sino Bioenergy has been growing earnings at an average annual rate of 33.2%, while the Commercial Services industry saw earnings growing at 11% annually.
Key information
33.2%
Earnings growth rate
34.0%
EPS growth rate
| Commercial Services Industry Growth | 8.5% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Sino Bioenergy makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 0 | 0 | 0 |
| 31 Mar 24 | 0 | 0 | 0 | 0 |
| 31 Dec 23 | 0 | 0 | 0 | 0 |
Quality Earnings: SFBE is currently unprofitable.
Growing Profit Margin: SFBE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if SFBE's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare SFBE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SFBE is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (14.8%).
Return on Equity
High ROE: SFBE's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.